Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Prostate cancer is one of the most prevalent male-specific diseases, where early and accurate diagnosis is essential for effective treatment and preventing disease progression. Assessing disease severity involves analyzing histological tissue samples, which are graded from 1 (healthy) to 5 (severely malignant) based on pathological features. However, traditional manual grading is labor-intensive and prone to variability. This study addresses the challenge of automating prostate cancer classification by proposing a novel histological grade analysis approach. The method integrates the gray-level co-occurrence matrix (GLCM) for extracting texture features with Haar wavelet modification to enhance feature quality. A convolutional neural network (CNN) is then employed for robust classification. The proposed method was evaluated using statistical and performance metrics, achieving an average accuracy of 97.3%, a precision of 98%, and an AUC of 0.95. These results underscore the effectiveness of the approach in accurately categorizing prostate tissue grades. This study demonstrates the potential of automated classification methods to support pathologists, enhance diagnostic precision, and improve clinical outcomes in prostate cancer care.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12344078PMC
http://dx.doi.org/10.1007/s10278-024-01363-9DOI Listing

Publication Analysis

Top Keywords

prostate cancer
16
prostate
5
combination deep
4
deep statistical
4
statistical features
4
features tissue
4
tissue pathology
4
pathology images
4
images classify
4
classify diagnose
4

Similar Publications

Background: With the advancement of MR-based imaging, prostate cancer ablative therapies have seen increased interest to reduce complications of prostate cancer treatment. Although less invasive, they do carry procedural risks, including rectal injury. To date, the medicolegal aspects of ablative therapy remain underexplored.

View Article and Find Full Text PDF

Background: Docetaxel is the most common chemotherapy regimen for several neoplasms, including advanced OSCC (Oral Squamous Cell Carcinoma). Unfortunately, chemoresistance leads to relapse and adverse disease outcomes.

Methods: We performed CRISPR-based kinome screening to identify potential players of Docetaxel resistance.

View Article and Find Full Text PDF

Effects of a Patient Decision Aid for Nonmetastatic Prostate Cancer Established in Routine Care: The Randomized Controlled EvEnt-PCA Trial.

Eur Urol Focus

September 2025

Department of Urology, Medical Centre, University of Heidelberg, Heidelberg, Germany; Department of Urology, Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany; Department of Urology, Philipps-University Marburg, Marburg, Germany.

Background And Objective: Since 2016, >21 000 patients with prostate cancer (PC) used our personalized online decision aid in routine care in Germany. We analyzed the effects of this online decision aid for men with nonmetastatic PC in a randomized controlled trial.

Methods: In the randomized controlled EvEnt-PCA trial, 116 centers performed 1:1 allocation of 1115 patients with nonmetastatic PC to use an online decision aid (intervention = I) or a printed brochure (control = C).

View Article and Find Full Text PDF